000 | 01548 a2200421 4500 | ||
---|---|---|---|
005 | 20250512053901.0 | ||
264 | 0 | _c19870109 | |
008 | 198701s 0 0 eng d | ||
022 | _a0317-1671 | ||
024 | 7 |
_a10.1017/s0317167100036672 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonnet, A M | |
245 | 0 | 0 |
_aA controlled study of oral vigabatrin (gamma-vinyl GABA) in patients with cerebellar ataxia. _h[electronic resource] |
260 |
_bThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques _cNov 1986 |
||
300 |
_a331-3 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAminocaproates _xadverse effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aFriedreich Ataxia _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeurologic Examination |
650 | 0 | 4 |
_aOlivopontocerebellar Atrophies _xdrug therapy |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aSpinocerebellar Degenerations _xdrug therapy |
650 | 0 | 4 | _aVigabatrin |
700 | 1 | _aEsteguy, M | |
700 | 1 | _aTell, G | |
700 | 1 | _aSchechter, P J | |
700 | 1 | _aHardenberg, J | |
700 | 1 | _aAgid, Y | |
773 | 0 |
_tThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques _gvol. 13 _gno. 4 _gp. 331-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1017/s0317167100036672 _zAvailable from publisher's website |
999 |
_c3471154 _d3471154 |